BIOMARKER:

Chr t(8;21) + KIT mutation

Entrez ID:

Related biomarkers:

‹

›

Chr t(8;21) + KIT mutation Chr t(8;21) + KIT mutation	Acute Myelogenous Leukemia AML	Chr t(8;21) + KIT mutation Chr t(8;21) + KIT mutation	Acute Myelogenous Leukemia AML	venetoclax + midostaurin Sensitive: C3 – Early Trials	venetoclax + midostaurin Sensitive: C3 – Early Trials
Chr t(8;21) + KIT mutation Chr t(8;21) + KIT mutation	Acute Myelogenous Leukemia AML	Chr t(8;21) + KIT mutation Chr t(8;21) + KIT mutation	Acute Myelogenous Leukemia AML	venetoclax Resistant: C3 – Early Trials	venetoclax Resistant: C3 – Early Trials
Chr t(8;21) + KIT mutation Chr t(8;21) + KIT mutation	Acute Myelogenous Leukemia AML	Chr t(8;21) + KIT mutation Chr t(8;21) + KIT mutation	Acute Myelogenous Leukemia AML	cabozantinib tablet Sensitive: D – Preclinical	cabozantinib tablet Sensitive: D – Preclinical